{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:13:04Z","timestamp":1792671184157,"version":"4.5.0"},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.56.8157","type":"journal-article","created":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T18:13:51Z","timestamp":1500056031000},"page":"1893-1896","source":"Crossref","is-referenced-by-count":3,"title":["Long-term Effects of Intravenous Cyclophosphamide in Combination with Mesna Provided Intravenously and via Bladder Perfusion in a Patient with Severe Multifocal Motor Neuropathy"],"prefix":"10.2169","volume":"56","author":[{"given":"Eri","family":"Iwasawa","sequence":"first","affiliation":[{"name":"Department of Neurology and Neurological Science, Graduate School of Medicine, Tokyo Medical and Dental University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Ohkubo","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurological Science, Graduate School of Medicine, Tokyo Medical and Dental University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Kanouchi","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Medical Hospital of Tokyo Medical and Dental University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kanda","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehiro","family":"Mizusawa","sequence":"additional","affiliation":[{"name":"National Institute of Neuroscience, National Center of Neurology and Psychiatry, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Yokota","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurological Science, Graduate School of Medicine, Tokyo Medical and Dental University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Beydoun SR, Copeland D. Bilateral phrenic neuropathy as a presenting feature of multifocal motor neuropathy with conduction block. Muscle Nerve 23: 556-559, 2000.","DOI":"10.1002\/(SICI)1097-4598(200004)23:4<556::AID-MUS15>3.0.CO;2-G"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Boonyapisit K, Katirji B. Multifocal motor neuropathy presenting with respiratory failure. Muscle Nerve 23: 1887-1890, 2000.","DOI":"10.1002\/1097-4598(200012)23:12<1887::AID-MUS16>3.0.CO;2-Y"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Feldman EL, Bromberg MB, Albers JW, Pestronk A. Immunosuppressive treatment in multifocal motor neuropathy. Ann Neurol 30: 397-401, 1991.","DOI":"10.1002\/ana.410300312"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Meucci N, Cappellari A, Barbieri S, Scarlato G, Nobile-Orazio E. Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 63: 765-769, 1997.","DOI":"10.1136\/jnnp.63.6.765"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Krarup C, Stewart JD, Sumner AJ, Pestronk A, Lipton SA. A syndrome of asymmetric limb weakness with motor conduction block. Neurology 40: 118-127, 1990.","DOI":"10.1212\/WNL.40.1.118"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Brannagan TH 3rd, Alaedini A, Gladstone DE. High-dose cyclophosphamide without stem cell rescue for refractory multifocal motor neuropathy. Muscle Nerve 34: 246-250, 2006.","DOI":"10.1002\/mus.20524"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Yokota T, Saito Y, Yuki N, Tanaka H. Persistent increased threshold of electrical stimulation selective to motor nerve in multifocal motor neuropathy. Muscle Nerve 19: 823-828, 1996.","DOI":"10.1002\/mus.880190702"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Van Schaik IN, Leger JM, Nobile-Orazio E, et al. European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-first revision. J Peripher Nerv Syst 15: 295-301, 2010.","DOI":"10.1111\/j.1529-8027.2010.00290.x"},{"key":"9","unstructured":"9. Van den Bergh PY, Hadden RD, Bouche P, et al. European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculopathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-First Revision. Eur J Neurol 17: 356-363, 2010."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Elkon KB, Stone VV. Type I interferon and systemic lupus erythematosus. J Interferon Cytokine Res 11: 803-812, 2011.","DOI":"10.1089\/jir.2011.0045"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Suzuki K, Rasband MN, Tohyama K, et al. Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J Neurosci 27: 3956-3967, 2007.","DOI":"10.1523\/JNEUROSCI.4401-06.2007"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hurd ER, Giuliano VJ. The effect of cyclophosphamide on B and T lymphocytes in patients with connective tissue diseases. Arthritis Rheum 18: 67-75, 1975.","DOI":"10.1002\/art.1780180113"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Chaudhry V, Cornblath DR. An open-label trial of rituximab (Rituxan<sup>\u00ae<\/sup>) in multifocal motor neuropathy. J Peripher Nerv Syst 15: 196-201, 2010.","DOI":"10.1111\/j.1529-8027.2010.00270.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Fitzpatrick AM, Mann CA, Barry S, Brennan K, Overell JR, Willison HJ. An open label clinical trial of complement inhibition in multifocal motor neuropathy. J Peripher Nerv Syst 16: 84-91, 2011.","DOI":"10.1111\/j.1529-8027.2011.00328.x"},{"key":"15","unstructured":"15. Van den Berg-Vos RM, Franssen H, Wokke JHJ, Van den Berg LH. Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment. Brain 125: 1875-1886, 2002."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Terenghi F, Cappellari A, Bersano A, Carpo M, Barbieri S, Nobile-Orazio E. How long is IVIg effective in multifocal motor neuropathy? Neurology 62: 666-668, 2004.","DOI":"10.1212\/01.WNL.0000110185.23464.A1"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Brock N, Pohl J. The development of mesna for regional detoxification. Cancer Treat Rev 10: 33-43, 1983.","DOI":"10.1016\/S0305-7372(83)80005-X"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/14\/56_56.8157\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T04:57:57Z","timestamp":1569819477000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/14\/56_56.8157\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":17,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.56.8157","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}